Touchstone International Medical Science Co Ltd (688013) — Net Asset Quality Index
Touchstone International Medical Science Co Ltd (688013) has a Net Asset Quality Index of 88.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥676.02 Million minus total liabilities of CN¥76.41 Million yields net assets of CN¥599.62 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Touchstone International Medical Science to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Touchstone International Medical Science Co Ltd Net Asset Quality Index Over Time (2017–2024)
This chart shows how Touchstone International Medical Science Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 88.7%, representing net assets of CN¥599.62 Million against total assets of CN¥676.02 Million CNY. See Touchstone International Medical Science (688013) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Touchstone International Medical Science Co Ltd (2017–2024)
The table below presents the year-by-year Net Asset Quality Index for Touchstone International Medical Science Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Touchstone International Medical Science (688013) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.2% | CN¥581.43 Million | CN¥637.24 Million | CN¥55.81 Million | ▲ +0.0 pp |
| 2023 | 91.2% | CN¥571.52 Million | CN¥626.61 Million | CN¥55.08 Million | ▼ -2.3 pp |
| 2022 | 93.6% | CN¥508.41 Million | CN¥543.46 Million | CN¥35.04 Million | ▼ -0.4 pp |
| 2021 | 94.0% | CN¥512.13 Million | CN¥544.83 Million | CN¥32.71 Million | ▼ -2.0 pp |
| 2020 | 96.0% | CN¥465.89 Million | CN¥485.24 Million | CN¥19.35 Million | ▲ +10.2 pp |
| 2019 | 85.8% | CN¥107.18 Million | CN¥124.91 Million | CN¥17.72 Million | ▲ +14.9 pp |
| 2018 | 70.9% | CN¥82.90 Million | CN¥116.95 Million | CN¥34.05 Million | ▼ -10.1 pp |
| 2017 | 81.0% | CN¥79.84 Million | CN¥98.57 Million | CN¥18.72 Million | — |